personalized cancer vaccine (Stemirna Therapeutics)

N/A

Report date: 2025/12/18 17:46:51

Base Information

Drug Namepersonalized cancer vaccine (Stemirna Therapeutics)
Drug Alias NamemRNA-based personalized cancer vaccine (Stemirna Therapeutics)mRNA-based personalized cancer vaccine encoding neoantigens (Stemirna Therapeutics)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A